We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Location Sciences Group Plc | LSE:LSAI | London | Ordinary Share | GB00BGT36S19 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 134.375 | 0.20 | 0.23 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Mgmt Invt Offices, Open-end | 111k | -758k | -0.1789 | -7.51 | 5.69M |
TIDMLSAI
RNS Number : 7317H
Location Sciences Group PLC
26 March 2020
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
26 March 2020
Location Sciences Group plc
("Location Sciences" or the "Company")
Result of General Meeting
Appointment of Joint Broker
and
Total Voting Rights
Result of Meeting
Location Sciences (AIM: LSAI), the leading location data verification company, announces that all Resolutions put to Shareholders at the General Meeting held earlier today were duly passed.
Accordingly, a re-organisation of the Company's share capital will occur with effect from close of business today comprising a sub-division of the Existing Ordinary Shares to create two classes of shares: New Ordinary Shares with a nominal value of 0.1 pence and New Deferred Shares with a nominal value of 0.9 pence.
The proportion of the issued ordinary share capital of the Company held by each Shareholder immediately before and after the Sub-division will remain unchanged. All entitlements under outstanding share options shall be recalculated accordingly as a result of the Sub-division.
Following the Sub-division, the ISIN code for the New Ordinary Shares will remain GB00BGT36S19 and the SEDOL code for the New Ordinary Shares will remain BGT36S1.
In addition, application has been made for, in aggregate, 114,858,571 New Ordinary Shares to be admitted to trading on AIM immediately following the Sub-division comprising; 111,430,000 Placing Shares, 1,142,857 Broker Shares and 2,285,714 Settlement Shares. Admission is expected to occur at 8.00 am on 27 March 2020.
As announced earlier today, certificates in relation to the Warrants will be posted to Placees by no later than 10 Business Days after Admission.
Appointment of Joint Broker
Peterhouse Capital Limited will be appointed as joint broker to the Company immediately following Admission.
Total Voting Rights
Following Admission, the Company will have 491,510,305 Ordinary Shares in issue admitted to trading on AIM. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
This announcement should be read in conjunction with the full text of the Circular which was posted to Shareholders on 9 March 2020, copies of which are available on the Company's website at www.locationsciencesgroup.ai. Capitalised terms in this announcement have the same meaning as given in the Circular.
This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.
For further information please contact:
Location Sciences Group PLC via Milk and Honey PR Mark Slade, Chief Executive Officer David Rae, Chief Financial Officer Shore Capital (Nomad and Broker) Tel: +44 (0)20 7408 4090 Tom Griffiths David Coaten Peterhouse Capital Tel: +44 (0) 20 7220 9791 Charles Goodfellow Eran Zucker Milk & Honey PR Tel: +44 (0)20 3637 7310 Kirsty Leighton Jessica Ballinger
The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.
About Location Sciences
Location Sciences is the pre-eminent global location verification provider to the $190 billion digital advertising industry, working in partnership with brands, media agencies and suppliers to reduce ad wastage and improve the effectiveness of location-based advertising campaigns.
The digital advertising marketplace remains unregulated and unmonitored, with an estimated $19 billion wasted on ad fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCBBGDXRSDDGGL
(END) Dow Jones Newswires
March 26, 2020 07:50 ET (11:50 GMT)
1 Year Location Sciences Chart |
1 Month Location Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions